Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
FEXOFENADINE HYDROCHLORIDE
G & A Licensing Limited
FEXOFENADINE HYDROCHLORIDE
180 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Withdrawn
2013-03-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Telfast 180mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 180 mg of fexofenadine hydrochloride (equivalent to 168mg of fexofenadine) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets. _Product imported from Italy:_ Peach, capsule-shaped, film-coated tablet debossed with an ‘e’ on one side and ‘018’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Relief of symptoms associated with chronic idiopathic urticaria. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ADULTS AND CHILDREN AGED 12 YEARS AND OVER_ The recommended dose of fexofenadine hydrochloride for adults and children aged 12 years and over is 180 mg once daily taken before a meal. Fexofenadine is a pharmacologically active metabolite of terfenadine. _CHILDREN UNDER 12 YEARS OF AGE_ The efficacy and safety of fexofenadine hydrochloride has not been studied in children under 12. _SPECIAL RISK GROUPS_ Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE As with most new drugs there is only limited data in the elderly and renally or hepatically impaired patients. Fexofenadine hydrochloride should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a drug class, have been associated with the adverse events, tachycardia and palpitations (see section 4.8). IRISH MEDICINES BOARD ____________________________________ Citiți documentul complet